For people who've plateaued on tirzepatide or semaglutide, essentially the most evidence-primarily based up coming phase in 2026 is optimizing The present protocol. Modifying dose timing, revisiting macronutrient distribution, or incorporating resistance instruction to preserve lean mass throughout